What is it about?

This study identifies homeodomain-interacting protein kinase 2 (HIPK2) as a prognostic biomarker candidate in patients with colorectal cancer and underscores a previously unknown functional link between HIPK2 and the KRAS signaling pathway providing thee rationale for future clinical studies and new treatment strategies for KRAS-mutated colon cancer

Featured Image

Read the Original

This page is a summary of: HIPK2 cooperates with KRAS signaling and associates with colorectal cancer progression, Molecular Cancer Research, January 2022, American Association for Cancer Research (AACR),
DOI: 10.1158/1541-7786.mcr-21-0628.
You can read the full text:

Read

Contributors

The following have contributed to this page